Autoimmunity BioSolutions
Develops genetically-guided therapy targeting sIL7R to treat autoimmune diseases including RA and lupus
Funding history
1 round- $1M
Develops genetically-guided therapy targeting sIL7R to treat autoimmune diseases including RA and lupus